Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-approval Study of New Enrolment Patients Undergoing Bilateral Treatment With the VisuMax SMILE Procedure

NCT05740293 is registered in ClinicalTrials.gov with Carl Zeiss Meditec, Inc. as lead sponsor.

NCT NCT05740293
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05740293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-approval Study of New Enrolment Patients Undergoing Bilateral Treatment With the VisuMax SMILE Procedure
Lead sponsor
Carl Zeiss Meditec, Inc.
Phase
Observational
Overall status
Completed
Start date
April 5, 2022
Completion date
August 25, 2025
Enrollment
186 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

astigmatism, myopia